反应详情

The title compound was prepared as described in Example 106, Step 2 with 2-{4-[(4-chloropyrimidin-2-yl)methyl]morpholin-2-yl}ethanol (50 mg, 0.19 mmol) and 2-amino-5-[2-fluoro-4-(1-hydroxy-1-methylethyl)phenyl]thiophene-3-carboxamide (57 mg, 0.19 mmol) as starting materials.